VLX-201

N/A

Report date: 2025/01/26 17:27:04

Base Information

Drug NameVLX-201
Drug Alias NameVLX-201
ClassificationBiologics
Mechanisms of ActionCytokines modulators
TargetsCytokines
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesValanx Biotech GmbH
China Registration ClassN/A

Develop Information

Active CompaniesValanx Biotech GmbH
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A